Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
06/2010
06/01/2010US7727957 Treatment and delay of outset of Parkinson's disease
06/01/2010US7727956 Deoxonadepsipeptides
06/01/2010US7727955 For the treatment of infantile colics; gastrointestinal disorders; neurokinin A; N alpha [N alpha (benzo[b]thiophenyl-2-ylcarbonyl)-1-aminocyclopentane-1-carbonyl]-D-phenylalanine-N-[3(morpholin-4-yl)propyl]amide; infant foods
06/01/2010US7727954 alleviating pain associated with neuromuscular or skeletal injury or inflammation by targeted delivery of therapeutic agents to inhibit inflammatory response which causes pain; controlled and directed delivery provided by drug depot implants, comprising therapeutic agent delivered to desired location
06/01/2010US7727953 acetyl-sarcosyl-glycyl-valyl-D-allo-isolucinyl-threoninyl-norvalyl-isolucinyl-arginyl-prolinyl-carboxylic acid; angiogensis inhibitors; anticancer agents
06/01/2010US7727952 Methods for treating spinal and bulbar muscular atrophy using LHRH analogs
06/01/2010US7727950 Methods and reagents for assaying protein kinase activity
06/01/2010US7727761 Vascular endothelial growth factor C (VEGF-C) protein and gene, mutants thereof, and uses thereof
06/01/2010US7727743 Method for stabilizing a cryoprecipitate of plasmatic proteins for being subjected to a viral inactivation thermal treatment
06/01/2010US7727713 Templated molecules and methods for using such molecules
06/01/2010US7727550 Biologically active native biomatrix composition
06/01/2010US7727542 Bioactive materials, methods of making bioactive materials and method of use thereof
06/01/2010US7727536 EG-VEGF nucleic acids and polypeptides and methods of use
06/01/2010US7727535 Protein comprising amino acid sequence with one to 20 amino acid substitutions, deletions or insertions; lower affinity binding to alpha thrombin, lower aggregation, or proteolysis resistance; inflammation, thrombosis, atherosclerosis, angioplasty-related restenosis; cardiovascular disorders
06/01/2010US7727533 Serpentine transmembrane antigens expressed in human cancers and uses thereof
06/01/2010US7727528 Tumor necrosis factor receptor 1 specific immunoglobulins for targeted immaging and treatment and diagnosis of cell proliferative and autoimmune disorders
06/01/2010US7727526 Use of PTHrP antagonists for treating renal cell carcinoma
06/01/2010US7727521 Method of ameliorating multi-organ failure resulting from ischemic reperfusion injury
06/01/2010US7727520 Method of promoting the healing of a chronic wound
06/01/2010US7727519 Method for treating hepatitis C virus with omega interferon
06/01/2010US7727518 Method of using IL-29 cysteine mutant to treat hepatitis C and hepatitis B
06/01/2010US7727441 forming the gel dispersion into a tube, extrusion to form a tubular tissue scaffold; comprising biopolymer fibers for use in propagation and culturing of tissues; tissue engineering and regenerative medicine; tissue grafting; prosthetics; cell therapy; useful in cardiovascular applications
06/01/2010CA2448737C Viral polymerase inhibitors
06/01/2010CA2431888C Amphiphilic lipid nanoparticles for peptide and/or protein incorporation
06/01/2010CA2415918C Agent for inhibiting adhesion of the pathogenic flora of the skin
06/01/2010CA2376025C Echinocandin derivatives, method for preparing same and application as antifungal agents
06/01/2010CA2336879C Sustained-release formulations comprising peptides, polypeptides, proteins or nucleic acids as active ingredients
06/01/2010CA2309925C Recombinant vaccines comprising immunogenic attenuated bacteria having rpos positive phenotype
06/01/2010CA2291851C Stabilized antithrombin iii preparation
06/01/2010CA2288600C A method for making multispecific antibodies having heteromultimeric and common components
06/01/2010CA2288373C Human cerberus protein
06/01/2010CA2221495C Methods and uses for apoptin
06/01/2010CA2219961C Vasopermeability enhancing peptide of human interleukin-2 and immunoconjugates thereof
06/01/2010CA2176249C Aerosol drug formulations for use with non-cfc propellants
06/01/2010CA2160800C Ctp modified gonadotropic proteins
06/01/2010CA2115839C Hla-restricted hepatitis b virus ctl epitopes
05/2010
05/27/2010WO2010060112A1 Peptidomimetic macrocycles with improved properties
05/27/2010WO2010060104A2 Implantable liposome embedded matrix composition, uses thereof, and polycaprolactone praticles as scaffolds for tissue regeneration
05/27/2010WO2010060088A2 Pathways to generate hair cells
05/27/2010WO2010060035A1 Snake factor v and methods of use as a procoagulant
05/27/2010WO2010059984A1 Il-29 mutants and uses thereof
05/27/2010WO2010059975A2 Method for modulating atherosclerosis
05/27/2010WO2010059942A1 Inhibition of apoe cleavage activity in the treatment of apoe-related disorders
05/27/2010WO2010059937A1 Cyclic carboxamide compounds and analogues thereof as of hepatitis c virus
05/27/2010WO2010059861A1 Compositions and methods to modulate hair growth
05/27/2010WO2010059733A1 Crystalline form of linaclotide
05/27/2010WO2010059727A1 Pyrazalone derivative formulations
05/27/2010WO2010059706A2 Translation factors as anti-aging drug targets
05/27/2010WO2010059315A1 Human serum albumin linkers and conjugates thereof
05/27/2010WO2010059204A1 Methods and compositions for treating obesity and related disorders
05/27/2010WO2010058819A1 Peptide capable of inhibiting interaction between human tumor protein mdm2 and human tumor suppression protein p53, and use thereof
05/27/2010WO2010058679A1 Fracture repair promoter
05/27/2010WO2010058427A2 Process for production and purification of polymyxin b sulfate
05/27/2010WO2010058364A1 Cosmetic and therapeutic use of proteins of dj-1 type for treating skin dryness
05/27/2010WO2010058238A1 Lantibiotic carboxyamide derivatives with enhanced antibacterial activity
05/27/2010WO2010058227A2 NOVEL USES OF VEGFxxxB
05/27/2010WO2010058106A1 Novel form of administering osteogenic protein complexes
05/27/2010WO2010058097A1 Truncated cd20 protein, deltacd20
05/27/2010WO2010057624A1 Method for preparing compositions comprising a protein, water and glycerol
05/27/2010WO2010057596A2 New therapy and medicament using integrin ligands for treating cancer
05/27/2010WO2010057330A1 Recombinant peptide molecule for treating saprolegniasis
05/27/2010WO2010057317A1 Liposomal composition for convection-enhanced delivery to the central nervous centre
05/27/2010WO2010057275A1 Cyclic peptides and uses thereof
05/27/2010WO2010057251A1 Peptide conjugates for suppressing an immune response, methods of making and uses therefor
05/27/2010WO2010057242A2 Vaccine
05/27/2010WO2010040096A3 Agonists of toll-like receptor 5 for the treatment of graft-versus-host disease
05/27/2010WO2010040051A3 Membrane resident peptide in anti-cancer peptides causes tumor cell necrosis rather than apoptosis of cancer cells
05/27/2010WO2010033249A8 Compositions of and methods of using ligand dimers
05/27/2010WO2010030936A3 Novel autophagy regulators atg14l and rubicon
05/27/2010WO2010030359A3 Macrocyclic hepatitis c serine protease inhibitors
05/27/2010WO2010028096A3 Peptides presenting an epitope of an a domain of factor h binding protein
05/27/2010WO2010026168A3 Fc gamma receptor for the treatment of b cell mediated multiple sclerosis
05/27/2010WO2010020677A3 Protein c variants
05/27/2010WO2010019275A9 Compositions and methods for treatment during non-acute periods following cns neurological injury
05/27/2010WO2010017403A3 Therapeutic compositions, devices and methods for observing treated tissues
05/27/2010WO2010017102A3 Secreted modular calcium binding protein for intracellular modulation of bone morphogenetic protein signaling
05/27/2010WO2010013934A3 Senescence control composition containing extracellular matrix components, and senescence control method for senescent cells using same
05/27/2010WO2010011347A3 Clip inhibitors and methods of modulating immune function
05/27/2010WO2010008573A3 Wound healing
05/27/2010WO2010006809A3 Medical use of the radical scavenger and antioxidant alpha-1-microglobulin
05/27/2010WO2010003144A3 Hypotensive peptides from soy proteins and method of preparation
05/27/2010WO2009155504A3 Methods for the modulation of angiogenesis
05/27/2010WO2009155055A3 Methods of effecting wnt signaling through dkk structural analysis
05/27/2010WO2009131698A3 PHOSPHORYLATED RECOMBINANT N-ACETYL-alpha-D- GLUCOSAMINIDASE (NaGlu) AND USES THEREOF
05/27/2010WO2009121848A3 Use of pseudomonas aeruginosa alkaline protease (apra) and inhibitors thereof in medicine and agriculture
05/27/2010WO2003031572A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
05/27/2010WO1990007321A3 Lymphocyte receptor homing sequences and their uses
05/27/2010US20100132060 Therapeuting compositions comprising an rnai agent and a neurotrophic factor and methods of use thereof
05/27/2010US20100130729 Mu-1, member of the cytokine receptor family
05/27/2010US20100130728 Taci-immunoglobulin fusion proteins
05/27/2010US20100130589 MODULATION OF eIF4E EXPRESSION
05/27/2010US20100130433 Casein-Derived Peptides having Anxiolytic Activity
05/27/2010US20100130432 Non-Natural Amino Acids and Neurotensin Analogues Thereof
05/27/2010US20100130431 Discordant helix stabilization for prevention of amyloid formation
05/27/2010US20100130430 Stabilized therapeutic small helical antiviral peptides
05/27/2010US20100130429 Bbs10 related diagnostic methods and reagents for bardet-biedl syndrome
05/27/2010US20100130428 Polymer factor ix moiety conjugates
05/27/2010US20100130427 Polymer-factor viii moiety conjugates
05/27/2010US20100130426 Compositions containing satiogens and methods of use
05/27/2010US20100130425 Use of toll-like receptor ligands in treating excitotoxic injury, ischemia and/or hypoxia
1 ... 630 631 632 633 634 635 636 637 638 639 640 641 642 643 644 645 646 647 648 649 650 ... 3163